Leslie Cho, MD, FACC, FESC, FSCAI, and Seth S. Martin, MD, MHS, FACC, FAHA, FASPC, open a discussion regarding therapies for statin-intolerant patients with ASCVD and provide an overview of the CLEAR Outcomes clinical trial.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
Bempedoic acid provides an effective treatment alternative for patients with statin intolerance due to differences in mechanisms of action.
Key opinion leaders discuss parameters and limitations of the CLEAR Outcomes clinical trial.
Medical experts highlight key findings from the CLEAR Outcomes trial.
Drs Cho and Martin examine the side effect profile associated with bempedoic acid.
In their final thoughts, the experts illustrate the overall effect of bempedoic acid for statin-intolerant patients with atherosclerotic cardiovascular disease.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The ripple effects of Medicare’s maximum fair price with Hiva Pourarsalan, Pharm.D. | AMCP Nexus 2026
2
How common is atopic dermatitis in the US? Not nearly as common as other research has shown, according to this study
3
5 things you should know about the midterms and healthcare
4
Targeted therapies for atopic dermatitis reduce hospitalizations and ER visits, but cost is a different story
5